Certara acquired Formedix for $41.4 million, a transaction completed in October 2023, structured as cash with contingent earn-out.
Formedix operates in Software, is based in United Kingdom (Formedix Limited). Formedix Limited provides a clinical metadata repository and clinical-trial data-flow automation software, adding metadata management and study-build automation to Certara's data platform. Certara completed the acquisition for total estimated consideration of approximately $41.4 million ($41.389 million), which included contingent consideration tied to eligible-revenue thresholds (potential earn-out up to roughly $9 million).
Add a metadata repository and clinical-trial automation to Certara's clinical data platform.
Added metadata repository and clinical data-flow automation to Certara's data platform.
Advisory firms were not disclosed for this transaction.